The region is not content to follow the pace of other European cities: its ambition is to establish itself as a driving force for medical innovation and biotechnology.
A strategic priority for the region
Health and biotechnology are at the core of the Madrid Regional Government’s economic strategy. Investments are being directed toward modernizing the hospital system, fostering biomedical research, and supporting the creation of specialized clusters. The ambition is clear: to make Madrid a European anchor point for medical R&D and breakthrough innovations.
The sector already represents close to 9% of the regional GDP, underlining its strategic weight and growth potential.
A dynamic business ecosystem
The region is increasingly attracting international health and life sciences companies. German leaders such as Fresenius and B. Braun are already expanding their operations in Madrid, taking advantage of a dynamic market and an environment geared toward innovation.
Alongside these global players, Spain counts more than 250 biotechnology companies, a significant share of which are concentrated in the Madrid region. This density fosters synergies between startups, hospitals, and multinational groups.
Madrid as a clinical innovation platform
The capital concentrates around 30 university hospitals and specialized centers actively engaged in next-generation clinical trials. This capacity makes Madrid a unique setting to rapidly validate new therapies and strengthen public-private partnerships in health innovation.
Initiatives such as the Madrid Science Park reinforce this dynamic, encouraging cooperation between startups, research centers, and large pharmaceutical or medtech companies.
A European ambition
By combining scientific excellence, clinical infrastructure, and an internationally oriented business ecosystem, Madrid is positioning itself not just as a gateway to the Spanish market, but as a strategic platform for biomedical R&D and growth in Southern Europe. A region ready to host and accelerate the most ambitious health and biotech projects.